Edmp Inc. lifted its stake in shares of Cigna Corp (NYSE:CI) by 5.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,942 shares of the health services provider’s stock after purchasing an additional 219 shares during the quarter. Edmp Inc.’s holdings in Cigna were worth $634,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently made changes to their positions in CI. Busey Wealth Management boosted its position in Cigna by 13.1% during the 1st quarter. Busey Wealth Management now owns 31,874 shares of the health services provider’s stock worth $5,126,000 after buying an additional 3,689 shares during the period. Raymond James Trust N.A. boosted its position in Cigna by 1.5% during the 1st quarter. Raymond James Trust N.A. now owns 15,552 shares of the health services provider’s stock worth $2,501,000 after buying an additional 224 shares during the period. Sciencast Management LP acquired a new stake in Cigna during the 1st quarter worth approximately $2,526,000. Retirement Systems of Alabama boosted its position in Cigna by 0.9% during the 1st quarter. Retirement Systems of Alabama now owns 176,973 shares of the health services provider’s stock worth $28,461,000 after buying an additional 1,640 shares during the period. Finally, Louisiana State Employees Retirement System boosted its position in Cigna by 0.7% during the 1st quarter. Louisiana State Employees Retirement System now owns 20,100 shares of the health services provider’s stock worth $3,232,000 after buying an additional 147 shares during the period. 88.31% of the stock is currently owned by institutional investors.
Shares of NYSE CI traded down $12.78 during midday trading on Tuesday, reaching $151.04. The stock had a trading volume of 6,381,824 shares, compared to its average volume of 2,833,889. The company has a market capitalization of $62.26 billion, a P/E ratio of 10.62, a price-to-earnings-growth ratio of 0.79 and a beta of 0.71. Cigna Corp has a twelve month low of $150.51 and a twelve month high of $226.60. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.42 and a current ratio of 0.42.
The business also recently announced a special dividend, which was paid on Wednesday, April 10th. Investors of record on Monday, March 11th were given a dividend of $0.04 per share. The ex-dividend date was Friday, March 8th. Cigna’s payout ratio is presently 0.28%.
In related news, Director John Partridge sold 1,000 shares of the business’s stock in a transaction on Thursday, February 7th. The shares were sold at an average price of $184.43, for a total transaction of $184,430.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director William D. Zollars sold 272 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total transaction of $45,812.96. The disclosure for this sale can be found here. Insiders have sold a total of 10,420 shares of company stock worth $1,886,122 in the last quarter. 0.80% of the stock is owned by corporate insiders.
Several equities research analysts recently commented on the stock. Zacks Investment Research upgraded shares of Cigna from a “hold” rating to a “buy” rating and set a $208.00 target price on the stock in a research report on Friday, January 4th. Morgan Stanley cut their target price on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 5th. Credit Suisse Group reiterated a “buy” rating and set a $250.00 target price on shares of Cigna in a research report on Monday, January 7th. ValuEngine downgraded shares of Cigna from a “hold” rating to a “sell” rating in a research report on Friday, December 28th. Finally, Stephens assumed coverage on shares of Cigna in a research report on Monday, January 14th. They set an “overweight” rating and a $251.00 target price on the stock. Two research analysts have rated the stock with a sell rating, two have given a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $231.28.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Further Reading: How to Invest in an Index Fund
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.